
Progenity Stock Is a Zero-or-Hero Holding for Biotech Bidders
Published on October 11, 2021
On the heels of a potent patent, short-squeeze target Progenity (PROG) offers excitement - and just maybe, outsized gains - for bold speculators.

On the heels of a potent patent, short-squeeze target Progenity (PROG) offers excitement - and just maybe, outsized gains - for bold speculators.